EBS · Emergent BioSolutions Inc.
Market Cap
$318.41M
Shares
51.27M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-09-01 | 2026-08-18 | |
| 10-Q | 2026-08-06 | 2026-06-30 | |
| 8-K | 2026-08-05 | — | |
| 8-K | 2026-06-29 | 2026-06-26 | |
| 10-Q | 2026-05-01 | 2026-03-31 | |
| 8-K | 2026-04-30 | — | |
| 8-K | 2026-04-30 | 2026-04-29 | |
| 8-K | 2026-04-17 | 2026-04-16 | |
| DEF 14A | 2026-03-20 | 2025-12-31 | |
| 8-K | 2026-03-03 | 2026-02-25 | |
| 10-K | 2026-02-27 | 2025-12-31 | |
| 8-K | 2026-02-26 | — | |
| 8-K | 2026-01-14 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-12-12 | — | |
| 8-K | 2025-11-12 | 2025-11-07 | |
| 10-Q | 2025-10-30 | 2025-09-30 | |
| 8-K | 2025-10-29 | — | |
| 8-K | 2025-09-11 | 2025-09-05 | |
| 8-K | 2025-09-05 | 2025-09-02 | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-08-06 | — | |
| 8-K | 2025-06-24 | 2025-06-23 | |
| 8-K | 2025-05-23 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-07 | — | |
| 8-K | 2025-05-06 | 2025-04-30 | |
| 8-K | 2025-03-31 | — | |
| 8-K | 2025-03-24 | 2025-03-19 | |
| DEF 14A | 2025-03-21 | 2024-12-31 | |
| 8-K | 2025-03-10 | — | |
| 10-K | 2025-03-04 | 2024-12-31 | |
| 8-K | 2025-03-03 | — | |
| 8-K | 2025-01-15 | — | |
| 8-K | 2025-01-14 | — | |
| 8-K | 2025-01-08 | 2024-12-12 | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-11-06 | — | |
| 8-K | 2024-10-04 | 2024-10-02 | |
| 8-K | 2024-10-02 | 2024-09-30 | |
| 8-K | 2024-09-17 | — | |
| 8-K | 2024-09-03 | 2024-08-30 | |
| 8-K | 2024-08-30 | 2024-08-29 | |
| 8-K | 2024-08-20 | — | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| 8-K | 2024-08-06 | — | |
| 8-K | 2024-07-31 | — | |
| 8-K | 2024-07-30 | — | |
| 8-K | 2024-07-12 | 2024-07-11 | |
| 8-K | 2024-07-08 | 2024-07-03 |
Showing 1–50 of 167 filings
Key facts
CIK
1367644
CUSIP
29089Q105
13F (30d)
158 filings
156 filers
Visit website
Investor relations